Skip to main content

Animations

MJFF Publications

8081 - 8090 of 8587 Results
Title
Year
  • Year
  • 2009
  • 2021
  • 2016
  • 2020
  • 2019
  • 2016
  • 2020
  • 2021
  • 2024
  • 2019
  • Summary Details
    OPEN
    Title: Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356
    Citation Count: 408
  • Summary Details
    OPEN
    Title: Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105368
    Citation Count: 23
  • Summary Details
    OPEN
    Title: A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease
    Journal Name: Cell Systems
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cels.2016.11.006
    Citation Count: 448
  • Summary Details
    RESTRICTED
    Title: White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study
    Journal Name: Progress in Neuro-Psychopharmacology and Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pnpbp.2020.109871
    Best OA location URL:
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-019-0164-x
    Citation Count: 145
  • Summary Details
    OPEN
    Title: LRRK2 Regulates Voltage-Gated Calcium Channel Function
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2016.00035
    Citation Count: 51
  • Summary Details
    OPEN
    Title: The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.12915
    Citation Count: 16
  • Summary Details
    OPEN
    Title: The potential of biomaterials for central nervous system cellular repair
    Journal Name: Neurochemistry International
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuint.2021.104971
    Citation Count: 30
  • Summary Details
    OPEN
    Title: LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-024-00403-2
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Altered dynamics of visual contextual interactions in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-019-0085-5
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.